CD8A and neoplasm: Biodistribution analyses showed tumor uptake exceeded blood level for [<sup>89</sup>Zr]Zr-anti-CD8-IgG2a<sub>silent</sub> and [<sup>89</sup>Zr]Zr-OT-I.